These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26867200)

  • 21. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docosahexaenoic acid and adult memory: a systematic review and meta-analysis.
    Yurko-Mauro K; Alexander DD; Van Elswyk ME
    PLoS One; 2015; 10(3):e0120391. PubMed ID: 25786262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omega-3 Supplementation and the Neural Correlates of Negative Affect and Impulsivity: A Double-Blind, Randomized, Placebo-Controlled Trial in Midlife Adults.
    Ginty AT; Muldoon MF; Kuan DCH; Schirda B; Kamarck TW; Jennings JR; Manuck SB; Gianaros PJ
    Psychosom Med; 2017 Jun; 79(5):549-556. PubMed ID: 28121722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults.
    Sueyasu T; Yasumoto K; Tokuda H; Kaneda Y; Obata H; Rogi T; Izumo T; Kondo S; Saito J; Tsukiura T; Nakai M
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Long Chain Omega-3 Polyunsaturated Fatty Acids on Brain Function in Mildly Hypertensive Older Adults.
    Howe PRC; Evans HM; Kuszewski JC; Wong RHX
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30279397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of long-chain omega-3 fish oils and multivitamins on cognitive and cardiovascular function: a randomized, controlled clinical trial.
    Pase MP; Grima N; Cockerell R; Stough C; Scholey A; Sali A; Pipingas A
    J Am Coll Nutr; 2015; 34(1):21-31. PubMed ID: 25565485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
    Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
    Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.
    Kidd PM
    Altern Med Rev; 2007 Sep; 12(3):207-27. PubMed ID: 18072818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
    Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of fish oil supplementation on brain DHA and EPA content and fatty acid profile in mice.
    Valentini KJ; Pickens CA; Wiesinger JA; Fenton JI
    Int J Food Sci Nutr; 2018 Sep; 69(6):705-717. PubMed ID: 29252041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population.
    Stough C; Downey L; Silber B; Lloyd J; Kure C; Wesnes K; Camfield D
    Neurobiol Aging; 2012 Apr; 33(4):824.e1-3. PubMed ID: 21531481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
    Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I
    J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial.
    van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Dullemeijer C; Olderikkert MG; Beekman AT; de Groot CP
    Neurology; 2008 Aug; 71(6):430-8. PubMed ID: 18678826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids.
    Wander RC; Du SH
    Am J Clin Nutr; 2000 Sep; 72(3):731-7. PubMed ID: 10966891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial.
    Malik A; Ramadan A; Vemuri B; Siddiq W; Amangurbanova M; Ali A; Welty FK
    Am J Clin Nutr; 2021 May; 113(5):1168-1176. PubMed ID: 33675344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
    Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
    Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supplementation with omega-3 polyunsaturated fatty acids augments brachial artery dilation and blood flow during forearm contraction.
    Walser B; Giordano RM; Stebbins CL
    Eur J Appl Physiol; 2006 Jun; 97(3):347-54. PubMed ID: 16770472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.